High Risk Superficial
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer (NCT02281383) | Memorial Sloan Kettering Cancer Center | 2014-10-01 |
Track High Risk Superficial automatically
Every clearance here is in the API, with alerts when new ones post.